Novel phenyl nitrogen mustard and half-mustard derivatives of distamycin A

[1]  R. C. Elderfield,et al.  Synthesis of Potential Anticancer Agents. XII. Nitrogen Mustards from p-Aminobenzoic Acid Derivatives1,2 , 1961 .

[2]  S. Penco,et al.  Structure and Synthesis of Distamycin A , 1964, Nature.

[3]  D. Triggle,et al.  A STUDY OF COMPARATIVE CHEMICAL AND BIOLOGICAL ACTIVITIES OF ALKYLATING AGENTS. , 1965, Journal of medicinal chemistry.

[4]  A. Leo,et al.  Structure-activity relationships in antitumor aniline mustards. , 1978, Journal of medicinal chemistry.

[5]  R. D'Alessio,et al.  Synthesis, DNA-binding properties, and antitumor activity of novel distamycin derivatives. , 1989, Journal of medicinal chemistry.

[6]  D. Ballinari,et al.  Biological profile of FCE 24517, a novel benzoyl mustard analogue of distamycin A. , 1991, British Journal of Cancer.

[7]  R. Souhami,et al.  The cytotoxicity, DNA crosslinking ability and DNA sequence selectivity of the aniline mustards melphalan, chlorambucil and 4-[bis(2-chloroethyl)amino] benzoic acid. , 1992, Biochemical pharmacology.

[8]  C. Maryanoff,et al.  Advances in medicinal chemistry , 1992 .

[9]  M. D’Incalci,et al.  In vitro cytotoxicity of GC sequence directed alkylating agents related to distamycin. , 1993, Journal of medicinal chemistry.

[10]  M. Waring,et al.  Molecular Aspects of Anticancer Drug/DNA Interactions , 1993 .

[11]  Moses Lee,et al.  Efficient Synthesis of Benzoic Acid Half Mustards , 1994 .

[12]  J. Hartley,et al.  Alkylation specificity for a series of distamycin analogues that tether chlorambucil. , 1997, Anti-cancer drug design.